SCHEMBL2291407

SCHEMBL2291407

O=C(Nc1ccccc1C(=O)O)c1ccc(Oc2cc(Cl)cc(Cl)c2)cc1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.71
MEN1 O00255 6/20 0.60
KMT2A Q03164 6/20 0.60
RAB9A P51151 3/20 0.60
NPC1 O15118 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
DHODH Q02127 1/20 0.58
ALDH1A1 P00352 3/20 0.56
HTT P42858 2/20 0.56
KCNH2 Q12809 1/20 0.56
PKM P14618 2/20 0.56
LMNA P02545 2/20 0.55
HPGD P15428 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
ABL1 P00519 1/20 0.55
GAA P10253 1/20 0.55
MAPT P10636 1/20 0.55
RIN1 Q13671 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2293960 0.91 SERPINE1 (0.76) SERPINE1MEN1KMT2ARAB9ANPC1
SCHEMBL2290709 0.90 SERPINE1 (0.76) SERPINE1MEN1KMT2ARAB9ANPC1
SCHEMBL2025586 0.89 MEN1 (0.72) SERPINE1MEN1KMT2ARAB9ANPC1
SCHEMBL30466712 0.89 MEN1 (0.72) SERPINE1MEN1KMT2ARAB9ANPC1
SCHEMBL2292518 0.88 SERPINE1 (0.71) SERPINE1MEN1KMT2ARAB9ANPC1
SCHEMBL2273110 0.87 SERPINE1 (0.60) SERPINE1MEN1KMT2APKMNPSR1
SCHEMBL2294521 0.86 SERPINE1 (0.66) SERPINE1MEN1KMT2ARAB9ANPC1
SCHEMBL8027764 0.85 MEN1 (0.67) SERPINE1MEN1KMT2ARAB9ANPC1
SCHEMBL2294821 0.84 SERPINE1 (0.62) SERPINE1MEN1KMT2ARAB9ANPC1
SCHEMBL13802449 0.83 ACLY (0.72) SERPINE1MEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989657-B2 Anthranilic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2011-08-02 US claimed
US-20090247637-A1 Novel Anthranilic Acid Derivatives DEHMLOW HENRIETTA 2009-10-01 US claimed
JP-2008546661-A 2008-12-25 JP claimed
EP-1896396-A1 ANTHRANILIC ACID DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-03-12 EP claimed
WO-2006134040-A1 ANTHRANILIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-12-21 WO claimed
US-20060281810-A1 Novel anthranilic acid derivatives HOFFMANN-LA ROCHE INC. 2006-12-14 US claimed
US-7989657-B2 Anthranilic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2011-08-02 US disclosed
US-20090247637-A1 Novel Anthranilic Acid Derivatives DEHMLOW HENRIETTA 2009-10-01 US disclosed
EP-1896396-A1 ANTHRANILIC ACID DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-03-12 EP disclosed
WO-2006134040-A1 ANTHRANILIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-12-21 WO disclosed
US-20060281810-A1 Novel anthranilic acid derivatives HOFFMANN-LA ROCHE INC. 2006-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060281810-A1 Novel anthranilic acid derivatives GPR84, HCAR1, GPR88 SERPINE1 3616/4885MEN1 1329/4885KMT2A 1519/4885
US-20090247637-A1 Novel Anthranilic Acid Derivatives GPR84, GPR88, HCAR1 SERPINE1 3954/4885MEN1 1049/4885KMT2A 1557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.